Table 2.
Proposed NET-biology framework across NEC subtypes.
| Subtype | Dominant upstream drivers | Likely NET position | Priority markers | Intervention implication |
|---|---|---|---|---|
| Classical inflammatory NEC (very preterm) | Dysbiosis, TLR4 signaling, feeding stress | Execution module of histone/protease injury and immunothrombosis | Tissue H3cit/MPO/NE co-localization; MPO-DNA, H3cit, fecal calprotectin | PAD4/DNase window plausible after bacterial control |
| Ischemia-dominant/cardiac-related NEC | Mesenteric hypoperfusion, venous congestion, platelet activation | Amplification of endothelial injury and microthrombosis rather than initiation | Platelet count/trajectory, CD177+ aggregates, mesenteric Doppler flow | Prefer platelet/endothelial nodes (IP6K1, TREM1) over global NET blockade |
| Transfusion-associated/viral-triggered | Immune-complex-like signals, complement, altered disease tolerance | Modulated by complement and tolerance state; contribution least established | Complement fragments, extracellular cold-inducible RNA-binding protein, NET panel | Exploratory only; no NET-directed inference yet |
| SIP/focal perforation | Localized wall stress, often minimal systemic inflammation | Probably distinct from segmental necrosis; do not pool with NEC | Perforation site histology, low systemic NET panel | Analyze separately in all NET studies |